Glucose prediction by analysis of exhaled metabolites – a systematic review

BMC Anesthesiology

Jan Hendrik Leopold³  Roosmarijn TM van Hooijdonk¹  Peter J Sterk²  Ameen Abu-Hanna³  Marcus J Schultz¹  Lieuwe DJ Bos² 

[1] Department of Intensive Care, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

[2] Department of Respiratory Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

[3] Department of Medical Informatics, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

关键词: Breath;    Volatile organic compound;    Monitoring;    Glucose;   

Others  :  816301
DOI  :  10.1186/1471-2253-14-46

 received in 2014-03-05, accepted in 2014-06-03,  发布年份 2014

【 摘 要 】

Background

In critically ill patients, glucose control with insulin mandates time– and blood–consuming glucose monitoring. Blood glucose level fluctuations are accompanied by metabolomic changes that alter the composition of volatile organic compounds (VOC), which are detectable in exhaled breath. This review systematically summarizes the available data on the ability of changes in VOC composition to predict blood glucose levels and changes in blood glucose levels.

Methods

A systematic search was performed in PubMed. Studies were included when an association between blood glucose levels and VOCs in exhaled air was investigated, using a technique that allows for separation, quantification and identification of individual VOCs. Only studies on humans were included.

Results

Nine studies were included out of 1041 identified in the search. Authors of seven studies observed a significant correlation between blood glucose levels and selected VOCs in exhaled air. Authors of two studies did not observe a strong correlation. Blood glucose levels were associated with the following VOCs: ketone bodies (e.g., acetone), VOCs produced by gut flora (e.g., ethanol, methanol, and propane), exogenous compounds (e.g., ethyl benzene, o–xylene, and m/p–xylene) and markers of oxidative stress (e.g., methyl nitrate, 2–pentyl nitrate, and CO).

Conclusion

There is a relation between blood glucose levels and VOC composition in exhaled air. These results warrant clinical validation of exhaled breath analysis to monitor blood glucose levels.

【 授权许可】

   
2014 Leopold et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Schultz MJ, Spronk PE, van Braam Houckgeest F: Glucontrol, no control, or out of control? Intensive Care Med 2010, 36:173-174. author reply 175–6
• [2]Schultz MJ, Harmsen RE, Spronk PE: Clinical review: strict or loose glycemic control in critically ill patients–implementing best available evidence from randomized controlled trials. Crit Care 2010, 14:223.
• [3]Finfer S, Wernerman J, Preiser J-C, Cass T, Desaive T, Hovorka R, Joseph JI, Kosiborod M, Krinsley J, Mackenzie I, Mesotten D, Schultz MJ, Scott MG, Slingerland R, Van den Berghe G, Van Herpe T: Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care 2013, 17:229.
• [4]Aragon D: Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 2006, 15:370-377.
• [5]Karon BS, Boyd JC, Klee GG: Glucose meter performance criteria for tight glycemic control estimated by simulation modeling. Clin Chem 2010, 56:1091-1097.
• [6]Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK: Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008, 4:214.
• [7]Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BØ: Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A 2007, 104:1777-1782.
• [8]Wopereis S, Rubingh CM, van Erk MJ, Verheij ER, van Vliet T, Cnubben NHP, Smilde AK, van der Greef J, van Ommen B, Hendriks HFJ: Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes. PLoS One 2009, 4:e4525.
• [9]Bijland LR, Bomers MK, Smulders YM: Smelling the diagnosis: a review on the use of scent in diagnosing disease. Neth J Med 2013, 71:300-307.
• [10]Roberts K, Jaffe A, Verge C: Noninvasive monitoring of glucose levels: is exhaled breath the answer? J Diabetes Sci Technol 2012, 6:659-664.
• [11]Turner C: Potential of breath and skin analysis for monitoring blood glucose concentration in diabetes. Expert Rev Mol Diagn 2011, 11:497-503.
• [12]Minh TDC, Blake DR, Galassetti PR: The clinical potential of exhaled breath analysis for diabetes mellitus. Diabetes Res Clin Pract 2012, 97:195-205.
• [13]Khan KS, Kunz R, Kleijnen J, Antes G: Five steps to conducting a systematic review. J R Soc Med 2003, 96:118-121.
• [14]Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
• [15]Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MMG, Sterne JAC, Bossuyt PMM, Group Q-2: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155:529-536.
• [16]Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hébert PC: Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005, 33:2778-2785.
• [17]Righettoni M, Schmid A, Amann A, Pratsinis SE: Correlations between blood glucose and breath components from portable gas sensors and PTR-TOF-MS. J Breath Res 2013, 7:037110.
• [18]Storer M, Dummer J, Lunt H, Scotter J, McCartin F, Cook J, Swanney M, Kendall D, Logan F, Epton M: Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes. J Breath Res 2011, 5:46011.
• [19]Fritsch T, van Herpen M, von Basum G, Hering P, Murtz M: Is exhaled carbon monoxide level associated with blood glucose level? A comparison of two breath analyzing methods. J Biomed Opt 2008, 13:34012.
• [20]Lee J, Ngo J, Blake D, Meinardi S, Pontello AM, Newcomb R, Galassetti PR: Improved predictive models for plasma glucose estimation from multi-linear regression analysis of exhaled volatile organic compounds. J Appl Physiol 2009, 107:155-160.
• [21]Turner C, Walton C, Hoashi S, Evans M: Breath acetone concentration decreases with blood glucose concentration in type I diabetes mellitus patients during hypoglycaemic clamps. J Breath Res 2009, 3:46004.
• [22]Minh TDC, Oliver SR, Ngo J, Flores R, Midyett J, Meinardi S, Carlson MK, Rowland FS, Blake DR, Galassetti PR: Noninvasive measurement of plasma glucose from exhaled breath in healthy and type 1 diabetic subjects. Am J Physiol Endocrinol Metab 2011, 300:E1166-E1175.
• [23]Boots AW, van Berkel JJ, Dallinga JW, Smolinska A, Wouters EF, Van Schooten FJ: The versatile use of exhaled volatile organic compounds in human health and disease. J Breath Res 2012, 6:27108.
• [24]White IR, Willis KA, Whyte C, Cordell R, Blake RS, Wardlaw AJ, Rao S, Grigg J, Ellis AM, Monks PS: Real-time multi-marker measurement of organic compounds in human breath: towards fingerprinting breath. J Breath Res 2013, 7:17112.
• [25]Jordan A, Haidacher S, Hanel G, Hartungen E, Märk L, Seehauser H, Schottkowsky R, Sulzer P, Märk TD: A high resolution and high sensitivity proton-transfer-reaction time-of-flight mass spectrometer (PTR-TOF-MS). Int J Mass Spectrom 2009, 286:122-128.
• [26]Spanĕl P, Smith D: Selected ion flow tube mass spectrometry for on-line trace gas analysis in biology and medicine. Eur J Mass Spectrom (Chichester, Eng) 2007, 13:77-82.
• [27]Paredi P, Biernacki W, Invernizzi G, Kharitonov SA, Barnes PJ: Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in BloodA new test for monitoring the disease? CHEST J 1999, 116:1007-1011.
• [28]Dolch ME, Frey L, Hornuss C, Schmoelz M, Praun S, Villinger J, Schelling G: Molecular breath-gas analysis by online mass spectrometry in mechanically ventilated patients: a new software-based method of CO(2)-controlled alveolar gas monitoring. J Breath Res 2008, 2:37010.
• [29]Bos LDJ, van Walree IC, Kolk AHJ, Janssen H-GH-G, Sterk PJ, Schultz MJ: Alterations of exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury. J Appl Physiol 2013, 115:jap.00685.2013.
• [30]Konvalina G, Haick H: Sensors for breath testing: from nanomaterials to comprehensive disease detection. Acc Chem Res 2013, 47:66-76.
• [31]Dalton P, Gelperin A, Preti G: Volatile metabolic monitoring of glycemic status in diabetes using electronic olfaction. Diabetes Technol Ther 2004, 6:534-544.
• [32]Galassetti PR, Novak B, Nemet D, Rose-Gottron C, Cooper DM, Meinardi S, Newcomb R, Zaldivar F, Blake DR: Breath ethanol and acetone as indicators of serum glucose levels: an initial report. Diabetes Technol Ther 2005, 7:115-123.
• [33]Pavlou AK, Turner AP: Sniffing out the truth: clinical diagnosis using the electronic nose. Clin Chem Lab Med 2000, 38:99-112.
• [34]Wang C, Mbi A, Shepherd M: A Study on breath acetone in diabetic patients using a cavity ringdown breath analyzer: exploring correlations of breath acetone with blood glucose and glycohemoglobin A1C. Sensors Journal, IEEE 2010, 10:54-63.
• [35]Deng C, Zhang J, Yu X, Zhang W, Zhang X: Determination of acetone in human breath by gas chromatography–mass spectrometry and solid-phase microextraction with on-fiber derivatization. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 810:269-275.
• [36]Spanĕl P: Acetone, ammonia and hydrogen cyanide in exhaled breath of several volunteers aged 4–83 years. J Breath Res 2007, 1:11001.
• [37]Hillman KM, Riordan T, O’farrell SM, Tabaqchali S: Colonization of the gastric contents in critically patients. Crit Care Med 1982, 10:444.
• [38]Bos LDJ, Wang Y, Weda H, Nijsen TME, Janssen APGE, Knobel HH, Vink TJ, Schultz MJ, Sterk PJ: A simple breath sampling method in intubated and mechanically ventilated critically ill patients. Respir Physiol Neurobiol 2013, 191C:67-74.
• [39]Novak BJ, Blake DR, Meinardi S, Rowland FS, Pontello A, Cooper DM, Galassetti PR: Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes. Proc Natl Acad Sci U S A 2007, 104:15613-15618.
• [40]Crader MK, Repine DJJ: Breath Biomarkers and the Acute Respiratory Distress Syndrome. J Pulm Respir Med 2012, 2:1-9.
• [41]Grapov D, Adams SH, Pedersen TL, Garvey WT, Newman JW: Type 2 diabetes associated changes in the plasma non-esterified fatty acids: oxylipins and endocannabinoids. PLoS One 2012, 7:e48852.
• [42]McCowen KC, Malhotra A, Bistrian BR: Stress-induced hyperglycemia. Crit Care Clin 2001, 17:107-124.